Professor David Wilson completed his PhD on infectious disease modelling in 2003, studying at Queensland University of Technology as well as at Oxford University and ETH Switzerland. He then completed a postdoctoral fellowship at University of California, Los Angeles on HIV epidemic modelling and optimal allocation of HIV antiretroviral drugs, informing World Health Organization guidelines and policy and practice for treatment roll-out in sub-Saharan Africa. He leads the Optima team, which conducts modelling, health economic and resource allocation studies for governments as well as regional and global health agencies and international donors. He was the winner of a Eureka Prize in 2013 and the Royal Society of NSW's Edgeworth David Medal in 2014. Professor Wilson has attracted around $60 million in competitive funding, published approximately 200 papers in academic journals, approximately 60 analytical and/or surveillance reports for national governments, and given more than 400 oral presentations at national and international conferences and workshops.
International Journal of Drug Policy
Dylan Vella-Horne, Rebecca Winter, Margaret Hellard, Mark Stoové, David P. Wilson, Alisa Pedrana, Joseph Doyle, Rebecca Winter, Margaret Hellard, Mark Stoové
International Journal of Drug Policy
Dylan Vella-Horne, Rebecca Winter, Margaret Hellard, Mark Stoové, David P. Wilson, Alisa Pedrana, Joseph Doyle, Rebecca Winter, Margaret Hellard, Mark Stoové
AIDS
David P. Wilson
This project aims to find out how Victorians are experiencing COVID-19 and responding to the measures introduced to stop the spread of the virus.
This project addresses critical knowledge gaps in Australian and global efforts to eliminate hepatitis C as a public health threat by 2030.